share_log
Benzinga ·  Apr 30 08:38
NRx Pharmaceuticals Says 'Both NRX-101 and Lurasidone, an Accepted Standard of Care in Bipolar Depression, Demonstrated Approximately 50% Reduction in Symptoms of Depression'
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment